Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database

The development of safe, effective, affordable vaccines against COVID-19 remains the cornerstone to mitigating this pandemic. Early in December 2020, multiple research groups had designed potential vaccines. From 11 March 2021, several European countries temporarily suspended the use of the Oxford–A...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobaiqy, Mansour, Elkout, Hajer, MacLure, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074142/
https://www.ncbi.nlm.nih.gov/pubmed/33923530
http://dx.doi.org/10.3390/vaccines9040393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074142/
https://www.ncbi.nlm.nih.gov/pubmed/33923530
http://dx.doi.org/10.3390/vaccines9040393

Ejemplares similares